ES2079176T3 - Agente de contraste para ecografia. - Google Patents

Agente de contraste para ecografia.

Info

Publication number
ES2079176T3
ES2079176T3 ES92901804T ES92901804T ES2079176T3 ES 2079176 T3 ES2079176 T3 ES 2079176T3 ES 92901804 T ES92901804 T ES 92901804T ES 92901804 T ES92901804 T ES 92901804T ES 2079176 T3 ES2079176 T3 ES 2079176T3
Authority
ES
Spain
Prior art keywords
ecography
contrast agent
contrast
polymeroxyethylenopolioxypropylene
lazyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92901804T
Other languages
English (en)
Other versions
ES2079176T5 (es
Inventor
Klaus-Dieter Beller
Rudolf Linder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6422745&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2079176(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of ES2079176T3 publication Critical patent/ES2079176T3/es
Application granted granted Critical
Publication of ES2079176T5 publication Critical patent/ES2079176T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Graft Or Block Polymers (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Fish Paste Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Radiation-Therapy Devices (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)

Abstract

SE DESCRIBE UNA PREPARACION ACUOSA QUE SE EMPLEA PARA LA ABSORCION Y ESTABILIZACION DE BURBUJAS DE MICROGAS, PARA LA UTILIZACION COMO MEDIO PARA CONTRASTAR ECOS, CONTENIENDO POLIMERO DE POLIOXIETILENOPOLIOXIPROPILENO Y FOSFOPOLIDA CARGADA NEGATIVAMENTE Y ES APROPIADO PARA LA REPRESENTACION DE LA ZONA IZQUIERDA DEL CORAZON.
ES92901804T 1991-01-09 1992-01-04 Agente de contraste para ecografia. Expired - Lifetime ES2079176T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4100470 1991-01-09
DE4100470A DE4100470A1 (de) 1991-01-09 1991-01-09 Echokontrastmittel

Publications (2)

Publication Number Publication Date
ES2079176T3 true ES2079176T3 (es) 1996-01-01
ES2079176T5 ES2079176T5 (es) 2007-10-16

Family

ID=6422745

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92901804T Expired - Lifetime ES2079176T5 (es) 1991-01-09 1992-01-04 Agente de contraste para ecografia.

Country Status (25)

Country Link
US (1) US5599523A (es)
EP (2) EP0566601B2 (es)
JP (1) JP3290655B2 (es)
KR (1) KR100203221B1 (es)
AT (1) ATE126708T1 (es)
AU (1) AU652803B2 (es)
BG (1) BG61667B2 (es)
CA (1) CA2098915C (es)
CZ (1) CZ280939B6 (es)
DE (3) DE4100470A1 (es)
DK (1) DK0566601T4 (es)
ES (1) ES2079176T5 (es)
FI (1) FI119913B (es)
GR (1) GR3017925T3 (es)
HK (1) HK1006147A1 (es)
HU (1) HU220763B1 (es)
IE (1) IE70131B1 (es)
IL (1) IL100607A (es)
NZ (1) NZ241246A (es)
PL (1) PL167253B1 (es)
RU (1) RU2091079C1 (es)
SK (1) SK278776B6 (es)
UA (1) UA27121C2 (es)
WO (1) WO1992011873A1 (es)
ZA (1) ZA92118B (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922304A (en) * 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US20010024638A1 (en) * 1992-11-02 2001-09-27 Michel Schneider Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
US6989141B2 (en) * 1990-05-18 2006-01-24 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
US6613306B1 (en) 1990-04-02 2003-09-02 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5578292A (en) 1991-11-20 1996-11-26 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US20040208826A1 (en) * 1990-04-02 2004-10-21 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
IN172208B (es) * 1990-04-02 1993-05-01 Sint Sa
US7083778B2 (en) * 1991-05-03 2006-08-01 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
USRE39146E1 (en) 1990-04-02 2006-06-27 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US20030194376A1 (en) * 1990-05-18 2003-10-16 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
AU636481B2 (en) * 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5993805A (en) 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
GB9107628D0 (en) 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
CA2119129C (en) * 1991-09-17 1999-11-09 Steven C. Quay Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media
US6875420B1 (en) 1991-09-17 2005-04-05 Amersham Health As Method of ultrasound imaging
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
US6723303B1 (en) 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
IL104084A (en) * 1992-01-24 1996-09-12 Bracco Int Bv Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
US5464696A (en) * 1992-08-13 1995-11-07 Bracco International B.V. Particles for NMR imaging
GB9221329D0 (en) 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Phase shift colloids as ultrasound contrast agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
NZ262237A (en) * 1993-01-25 1997-06-24 Sonus Pharma Inc Ultrasound contrast agents comprising phase shift colloids having a boiling point below the body temperature of the animal it is used in
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
ES2231775T5 (es) * 1993-07-30 2011-02-02 Imcor Pharmaceutical Co. Composición de microburbujas estabilizadas para ecografía.
US5798091A (en) * 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
DE4328642A1 (de) * 1993-08-26 1995-03-02 Byk Gulden Lomberg Chem Fab Ultraschallkontrastmittel
GB9318288D0 (en) * 1993-09-03 1993-10-20 Nycomed Imaging As Improvements in or relating to contrast agents
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
PL182223B1 (pl) 1993-12-15 2001-11-30 Bracco Research Sa Biokompatybilna faza rozproszona do otrzymywania srodka kontrastowego do badan ultradzwiekowych, srodek kontrastowy do badan ultradzwiekowych, suchy preparat srodka kontrastowego oraz dwuskladnikowy zestaw do otrzymywania srodka kontrastowego do badan ultradzwiekowych PL PL PL
GB9417941D0 (en) * 1994-09-06 1994-10-26 Nycomed Imaging As Improvements in or relating to contrast agents
US5540909A (en) * 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5804162A (en) 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
WO2004073750A1 (en) 1995-06-07 2004-09-02 Harald Dugstad Improvements in or relating to contrast agents
DE69721235T2 (de) * 1996-02-19 2004-02-05 Amersham Health As Verbesserungen an (oder im bezug auf) kontrastmittel
DK0904113T3 (da) * 1996-03-05 2004-08-30 Acusphere Inc Mikroindkapslede fluorerede gasser til anvendelse som billeddannende midler
AU736301B2 (en) 1996-05-01 2001-07-26 Imarx Therapeutics, Inc. Methods for delivering compounds into a cell
DE19626530A1 (de) * 1996-07-02 1998-01-15 Byk Gulden Lomberg Chem Fab MR-Kontrastmittelzubereitungen
KR100593873B1 (ko) * 1996-08-02 2006-07-03 지이 헬스케어 에이에스 조영제
US6017310A (en) * 1996-09-07 2000-01-25 Andaris Limited Use of hollow microcapsules
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US6068600A (en) * 1996-12-06 2000-05-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules
US6054118A (en) * 1997-01-22 2000-04-25 Nycomed Imaging As Contrast agents comprising two types of gas-containing microparticles
GB9701237D0 (en) * 1997-01-22 1997-03-12 Nycomed Imaging As Improvements in or relating to contrast agents
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19805012A1 (de) * 1998-02-07 1999-08-12 Thomas Gieselmann Kontrastmittel zur Verwendung als Diagnostikum bei bildgebenden Verfahren sowie seine Herstellung
GB9912356D0 (en) 1999-05-26 1999-07-28 Btg Int Ltd Generation of microfoam
US8512680B2 (en) 2001-08-08 2013-08-20 Btg International Ltd. Injectables in foam, new pharmaceutical applications
US8048439B2 (en) 2003-11-17 2011-11-01 Btg International Ltd. Therapeutic foam
WO2005048976A2 (en) 2003-11-17 2005-06-02 Btg International Limited Foams comprising a sclerosing and a viscosity enhancing agent, methods for production thereof
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
GB0509824D0 (en) 2005-05-13 2005-06-22 Btg Int Ltd Therapeutic foam
WO2007070827A2 (en) * 2005-12-15 2007-06-21 Bristol-Myers Squibb Pharma Company Contrast agents for myocardium perfusion imaging

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3141641A1 (de) * 1981-10-16 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Ultraschall-kontrastmittel und dessen herstellung
US4900540A (en) * 1983-06-20 1990-02-13 Trustees Of The University Of Massachusetts Lipisomes containing gas for ultrasound detection
ZA888577B (en) * 1987-11-27 1989-08-30 Akzo Nv Stabilization of antibodies
IN172208B (es) † 1990-04-02 1993-05-01 Sint Sa

Also Published As

Publication number Publication date
ATE126708T1 (de) 1995-09-15
JP3290655B2 (ja) 2002-06-10
DE4100470A1 (de) 1992-07-16
DK0566601T4 (da) 2007-05-29
FI119913B (fi) 2009-05-15
WO1992011873A1 (de) 1992-07-23
AU652803B2 (en) 1994-09-08
EP0566601A1 (de) 1993-10-27
SK278776B6 (sk) 1998-02-04
CZ178093A3 (en) 1994-04-13
DE4290068D2 (de) 1993-10-07
EP0566601B1 (de) 1995-08-23
KR100203221B1 (ko) 1999-06-15
KR930703023A (ko) 1993-11-29
US5599523A (en) 1997-02-04
HU9301703D0 (en) 1993-09-28
ZA92118B (en) 1992-08-26
HUT64239A (en) 1993-12-28
FI933137L (fi) 1993-07-08
IE70131B1 (en) 1996-10-30
NZ241246A (en) 1994-01-26
JP2000509363A (ja) 2000-07-25
GR3017925T3 (en) 1996-01-31
RU2091079C1 (ru) 1997-09-27
CA2098915A1 (en) 1992-07-10
PL167253B1 (pl) 1995-08-31
SK72993A3 (en) 1994-04-06
IE920038A1 (en) 1992-07-15
EP0494615A1 (de) 1992-07-15
AU1154792A (en) 1992-08-17
HU220763B1 (hu) 2002-05-28
IL100607A (en) 1996-07-23
DK0566601T3 (da) 1995-12-18
IL100607A0 (en) 1992-09-06
CA2098915C (en) 2005-05-17
UA27121C2 (uk) 2000-02-28
ES2079176T5 (es) 2007-10-16
EP0566601B2 (de) 2007-02-21
CZ280939B6 (cs) 1996-05-15
DE59203392D1 (de) 1995-09-28
FI933137A0 (fi) 1993-07-08
BG61667B2 (bg) 1998-02-27
HK1006147A1 (en) 1999-02-12

Similar Documents

Publication Publication Date Title
ES2064121T3 (es) Agente para reducir o eliminar el crecimiento de los pelos del cuerpo humano.
ES2089954B1 (es) Metodo para preparar una emulsion de hidrocarburo viscoso en solucion tampon acuosa.
ES2170250T3 (es) Articulo absorbente desechable que tiene una lamina superior con locion y que contiene un emoliente y un agente inmovilizante de poliester de poliol.
ES2035384T3 (es) Procedimiento para la esterilizacion de sangre, plasma, derivados de la sangre y del plasma, suspensiones celulares o similares.
ES2054649T3 (es) 2-aminotetralinas basicas substituidas.
ES2089930T3 (es) Gel acuoso de maquillaje con organopolisiloxano.
AR241684A1 (es) Toallita higienica.
ES2133130B1 (es) Nueva formulacion de budesonida, su uso y recipiente que la contiene.
BR0214264A (pt) Composição, processo de preparação da composição e seus usos
DE60238212D1 (de) Cellulosematerial mit verbesserter saugfähigkeit
PE100799A1 (es) Dispositivo interlabial absorbente
ES2058284T3 (es) Preparado capilar.
ES2108118T3 (es) Composicion dialdehidica antimicrobiana y metodos de uso.
KR930703023A (ko) 반향 조영제
ES2062229T3 (es) Formulacion extrasuave de gel de ducha y de champu para los cabellos con baja concentracion de agentes tensioactivos.
ES2040137T3 (es) Agente para la tincion del pelo y su empleo.
ES2018154B3 (es) Medios para la determinacion de la actividad de la peroxidasa con estabilizador, procedimiento para su obtencion y su utilizacion.
ES2079407T3 (es) Suspension acuosa de hidroxietilcelulosa.
AR000504A1 (es) Procedimiento para la producción de una solución acuosa biocida de acción prolongada basada en ionesperacéticos
BR9901609A (pt) Artigo absorvente descartável de fluìdos corporais.
ES2081069T3 (es) Composicion antipelicular a base de sulfuro de selenio.
ES2127277T3 (es) Utilizacion de microcapsulas como agentes de contraste para la sonografia por efecto doppler en color.
ES2135772T3 (es) Concentrados tensioactivos acuosos bombeables.
ES2172558T3 (es) Lubricante compatible con radiaciones para dispositivos medicos.
KR920014474A (ko) 담석 붕괴용 제제

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 566601

Country of ref document: ES